BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23581871)

  • 21. Severe creatine kinase increase during quetiapine and mirtazapine treatment.
    Apikoglu Rabus S; Izzettin F; Rabus M; Bilici M
    Psychopharmacology (Berl); 2006 Apr; 185(2):263-4. PubMed ID: 16374598
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia.
    Traynor K
    Am J Health Syst Pharm; 2009 May; 66(10):880, 882. PubMed ID: 19420301
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel treatment option of bipolar depression with psychotic and catatonic features.
    Di Michele V; Bolino F
    Gen Hosp Psychiatry; 2006; 28(4):364-5. PubMed ID: 16814640
    [No Abstract]   [Full Text] [Related]  

  • 24. Quetiapine treatment for mania secondary to brain injury in 2 patients.
    Daniels JP; Felde A
    J Clin Psychiatry; 2008 Mar; 69(3):497-8. PubMed ID: 18402501
    [No Abstract]   [Full Text] [Related]  

  • 25. Quetiapine fumarate for schizophrenia and bipolar disorder in young patients.
    Ribolsi M; Magni V; Rubino IA
    Drugs Today (Barc); 2010 Aug; 46(8):581-7. PubMed ID: 20830318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors.
    Denys D; de Geus F; van Megen HJ; Westenberg HG
    J Clin Psychiatry; 2004 Aug; 65(8):1040-8. PubMed ID: 15323587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of quetiapine in bipolar disorder: a case series with prospective evaluation.
    Suppes T; McElroy SL; Keck PE; Altshuler L; Frye MA; Grunze H; Leverich GS; Nolen WA; Chisholm K; Dennehy EB; Post RM
    Int Clin Psychopharmacol; 2004 May; 19(3):173-4. PubMed ID: 15107662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
    Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
    J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
    [No Abstract]   [Full Text] [Related]  

  • 29. Second-generation antipsychotics cause weight gain in youths.
    Harv Ment Health Lett; 2010 Jan; 26(7):7. PubMed ID: 20217902
    [No Abstract]   [Full Text] [Related]  

  • 30. Quetiapine-related tardive dyskinesia.
    Ghaemi SN; Ko JY
    Am J Psychiatry; 2001 Oct; 158(10):1737. PubMed ID: 11579018
    [No Abstract]   [Full Text] [Related]  

  • 31. Quetiapine-associated hypomania in a woman with schizoaffective disorder.
    Benazzi F
    Can J Psychiatry; 2001 Mar; 46(2):182-3. PubMed ID: 11280090
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
    Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
    Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine alone and added to a mood stabilizer for serious mood disorders.
    Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR
    J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy.
    Bora E; Saffet Gonul A; Akdeniz F; Vahip S
    Eur Psychiatry; 2003 Oct; 18(6):323. PubMed ID: 14611931
    [No Abstract]   [Full Text] [Related]  

  • 35. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pooled analysis of adjunct extended-release quetiapine fumarate in patients with major depressive disorder according to ongoing SSRI or SNRI treatment.
    Bauer M; Demyttenaere K; El-Khalili N; Thase ME; Papakostas GI; Szamosi J; Earley WR; Eriksson H
    Int Clin Psychopharmacol; 2014 Jan; 29(1):16-25. PubMed ID: 24108148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quetiapine: a review of its use in acute mania and depression associated with bipolar disorder.
    Dando TM; Keating GM
    Drugs; 2005; 65(17):2533-51. PubMed ID: 16296876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quetiapine: a review of its use in the treatment of bipolar depression.
    Keating GM; Robinson DM
    Drugs; 2007; 67(7):1077-95. PubMed ID: 17488148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Branch retinal vein occlusion associated with quetiapine fumarate.
    Yong KC; Kah TA; Ghee YT; Siang LC; Bastion ML
    BMC Ophthalmol; 2011 Aug; 11():24. PubMed ID: 21867521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute nonpsychotic mania: first episode.
    Allen MH
    CNS Spectr; 2009 Nov; 14(11 Suppl 11):3-6; discussion 12-4. PubMed ID: 20173693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.